Sunshine Biopharma Inc.

Sunshine Biopharma Inc. financial statements

Sunshine Biopharma Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 36.31M10-K
Net income−USD 5.98M10-K
Cash and equivalentsUSD 9.12M10-Q
Total debtUSD 812.42KEODHD

Sunshine Biopharma Inc. financials on 6ix · Sunshine Biopharma Inc. on 6ix